Literature DB >> 18632835

Atrial fibrillation in heart failure: the chicken or the egg?

R Balasubramaniam1, P M Kistler.   

Abstract

Atrial fibrillation (AF) and heart failure (HF) are the emerging epidemics of cardiovascular disease in the new millennium. Both are responsible for considerable morbidity and mortality and health budget expenditure. The advent of catheter ablation for patients with AF has provided important new insights into the relative contribution of AF to left ventricular dysfunction. The aim of this review is to discuss the complex interplay in the pathophysiology of AF and HF to improve our understanding of the basis for current treatment strategies and guide future research direction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632835     DOI: 10.1136/hrt.2007.140640

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  4 in total

Review 1.  Imaging for Risk Stratification in Atrial Fibrillation with Heart Failure.

Authors:  Kennosuke Yamashita; Ravi Ranjan
Journal:  Cardiol Clin       Date:  2019-02-22       Impact factor: 2.213

Review 2.  Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.

Authors:  Christopher J Boos; Michael Nam; A J Camm
Journal:  Heart Fail Rev       Date:  2013-06-25       Impact factor: 4.214

3.  Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition.

Authors:  Antonis S Manolis; Theodora A Manolis; Antonis A Manolis; Helen Melita
Journal:  Heart Fail Rev       Date:  2022-03-23       Impact factor: 4.654

Review 4.  The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials.

Authors:  Yu Chen; Shaoping Nie; Hai Gao; Tao Sun; Xiaoqiu Liu; Fei Teng; Yanhui Xing; Wen Chen; Zhenpeng Zhang; Yonghong Gao; Jie Wang; Yanwei Xing; Hongcai Shang
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-04       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.